Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 10Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 9Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Hematologic Neoplasms 4Lymphoma, T-Cell, Peripheral 3Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Hodgkin Disease 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Spondylolisthesis 1Spinal Stenosis 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1

Interventions

Prednisolone 1Methylprednisolone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neurotoxicity Syndromes × Lymphoid × Clear all
NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡